US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 1.300
  • -0.090-6.47%
Close Nov 21 16:00 ET
  • 1.330
  • +0.030+2.31%
Post 16:47 ET
21.96MMarket Cap-1192P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acurx Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.19
-0.17
+0.02
Beat Est.
+20.84%
+29.17%
+10.48%
Analyst Rating
Buy

Nov 12, 2024

Acurx Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Aug 9, 20242024/Q20.000 / 0.000--
May 15, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Aug 9, 20242024/Q20.000 / 0.000--
May 15, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Acurx Pharmaceuticals Earnings Reports

  • Acurx Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 13 05:46

  • Acurx Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:53

  • Acurx Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 15 04:43

  • Acurx Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 16 04:14

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data